These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27531684)

  • 1. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
    Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
    Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.
    Singal AG; Tiro JA; Murphy CC; Blackwell JM; Kramer JR; Khan A; Liu Y; Zhang S; Phillips JL; Hernaez R
    Clin Gastroenterol Hepatol; 2021 May; 19(5):987-995.e1. PubMed ID: 32629122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
    Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.
    Dalton-Fitzgerald E; Tiro J; Kandunoori P; Halm EA; Yopp A; Singal AG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):791-8.e1. PubMed ID: 25019694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance.
    Wong RJ; Jones PD; Niu B; Therapondos G; Thamer M; Kshirsagar O; Zhang Y; Pinheiro P; Kyalwazi B; Fass R; Khalili M; Singal AG
    JAMA Netw Open; 2024 May; 7(5):e2411076. PubMed ID: 38743424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma.
    Singal AG; Volk ML; Rakoski MO; Fu S; Su GL; McCurdy H; Marrero JA
    J Clin Gastroenterol; 2011 Sep; 45(8):727-32. PubMed ID: 21602704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
    Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
    JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
    Moon AM; Swier RM; Lane LM; Barritt AS; Sanoff HK; Olshan AF; Wheeler SB; Ioannou GN; Kim NJ; Hagan S; Vutien P; Benefield T; Henderson LM
    Dig Dis Sci; 2024 Jul; 69(7):2437-2449. PubMed ID: 38652392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
    van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.
    Singal AG; Tiro JA; Murphy CC; Marrero JA; McCallister K; Fullington H; Mejias C; Waljee AK; Pechero Bishop W; Santini NO; Halm EA
    Hepatology; 2019 Jan; 69(1):121-130. PubMed ID: 30070379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
    Chalasani N; Said A; Ness R; Hoen H; Lumeng L
    Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
    Zhao C; Nguyen MH
    J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
    Davila JA; Morgan RO; Richardson PA; Du XL; McGlynn KA; El-Serag HB
    Hepatology; 2010 Jul; 52(1):132-41. PubMed ID: 20578139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
    Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
    Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.
    Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG
    Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.
    Simmons OL; Feng Y; Parikh ND; Singal AG
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):766-773. PubMed ID: 30056183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.